Filter by
Filter by
Longitudinal Assessment of Quality of Life in Nasopharyngeal Cancer Patients Treated with Intensity-Modulated Proton Therapy and Volumetric Modulated Arc Therapy at Different Time Points.
This is a longitudinal assessment of QoL on 287 NPC patients treated with IMPT (n=41) and VMAT (n=246). Both groups exhibited improved scores of global QoL...
Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
This study from Japan reported clinical outcomes of 43 patient with operable stage IA or IB NSCLC treated with a dose of 66 GyRBE in 10 fractions for peripheral...
Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
This study by the Samsung group, Korea, reported clinical outcomes of 27 patients with inoperable early stage NSCLC treated by protons to a total dose of 64...
Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis. This review.
Published in the Green Journal, this systematic review analyzed 160 studies of hypofractionated PT (n=11) or XRT (n=148) or PT+XRT (n=1) for localized prostate...
A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer.
This study from Japan reported 45 cases of localized prostate cancer treated with real-time image-gated spot-scanning proton therapy (RGPT) where 3 to 4 pure...
Evidence for external beam radiotherapy in mediastinal Hodgkin and non-Hodgkin lymphoma - systematic review.
This review included 11 studies representing a total of 529 patients. The findings include 1) the OS for 2 years varied from 91% - 98% for 5 of the included...
PTCOG NA Symposium: hypofractionation and SBRT with proton therapy
New Avenues in Proton Therapy: Hypofractionation, SBRT, and ConformalFLASH®
A systematic review and meta-analysis of radiotherapy and particle beam therapy for skull base chondrosarcoma: TRP-chondrosarcoma 2024.
Based on 21 original studies, this meta-analysis reported a significant association of PT with a superior 5-year OS rate compared to three-dimensional conformal...